Elliot Ehrich
Direttore Tecnico/Scientifico/R&S presso LifeMine Therapeutics, Inc.
Profilo
Elliot W.
Ehrich is currently the Director at Evecxia, Inc. and the Chief Medical Officer & EVP-Translational Science at LifeMine Therapeutics, Inc. He previously worked as the Senior Director-Clinical Research at Merck & Co., Inc., Director at Nido Biosciences, Inc., Research Associate at The European Molecular Biology Laboratory, Chief Medical Officer, SVP-Research & Development at Alkermes, Inc., and Chief Medical Officer, EVP-Research & Development at Alkermes Plc.
He was also the President at Skyhawk Therapeutics, Inc. Dr. Ehrich received his undergraduate degree from Princeton University and his doctorate from Columbia University College of Physicians & Surgeons.
Posizioni attive di Elliot Ehrich
Società | Posizione | Inizio |
---|---|---|
LifeMine Therapeutics, Inc.
LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | 04/12/2022 |
Evecxia, Inc.
Evecxia, Inc. Miscellaneous Commercial ServicesCommercial Services Evecxia, Inc. is engaged in biotechnology services. The company was founded by Jacob Jacobsen and Marc Caron and is headquartered in Research Triangle Park, NC. | Direttore/Membro del Consiglio | 30/10/2023 |
Precedenti posizioni note di Elliot Ehrich
Società | Posizione | Fine |
---|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Direttore Tecnico/Scientifico/R&S | 16/09/2011 |
Skyhawk Therapeutics, Inc.
Skyhawk Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Skyhawk Therapeutics, Inc. discovers and develops small molecule therapeutics for RNA-based disease. It is developing drug candidates for cancer, neurological disease, and rare disease. The company was founded by William M. Hanley III and Kathleen McCarthy and is headquartered in Waltham, MA. | Presidente | - |
Nido Biosciences, Inc.
Nido Biosciences, Inc. BiotechnologyHealth Technology Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA. | Direttore/Membro del Consiglio | - |
The European Molecular Biology Laboratory | Corporate Officer/Principal | - |
ALKERMES PLC | Corporate Officer/Principal | - |
Formazione di Elliot Ehrich
Princeton University | Undergraduate Degree |
Columbia University College of Physicians & Surgeons | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
ALKERMES PLC | Health Technology |
Aziende private | 5 |
---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Nido Biosciences, Inc.
Nido Biosciences, Inc. BiotechnologyHealth Technology Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA. | Health Technology |
Skyhawk Therapeutics, Inc.
Skyhawk Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Skyhawk Therapeutics, Inc. discovers and develops small molecule therapeutics for RNA-based disease. It is developing drug candidates for cancer, neurological disease, and rare disease. The company was founded by William M. Hanley III and Kathleen McCarthy and is headquartered in Waltham, MA. | Health Technology |
LifeMine Therapeutics, Inc.
LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Health Technology |
Evecxia, Inc.
Evecxia, Inc. Miscellaneous Commercial ServicesCommercial Services Evecxia, Inc. is engaged in biotechnology services. The company was founded by Jacob Jacobsen and Marc Caron and is headquartered in Research Triangle Park, NC. | Commercial Services |
- Borsa valori
- Insiders
- Elliot Ehrich